Chicago, IL – New research presented at ENDO 2026, the Endocrine Society’s annual meeting, reveals a concerning link between early-life exposure to a widely used plastic chemical and heightened anxiety levels in adult male rats. The findings, originating from the University of Buenos Aires School of Medicine, suggest that prenatal and immediate postnatal exposure to di-(2-ethylhexyl) phthalate (DEHP) can induce long-lasting behavioral changes, raising potential implications for human health.
The study, led by Osvaldo Juan Ponzo, M.D., Ph.D., professor of physiology at the University of Buenos Aires, highlights the potent effects of endocrine-disrupting chemicals (EDCs) during critical developmental windows. "This research demonstrates that one of the most widely used plasticizers worldwide is capable of causing behavioral changes when the subject is exposed during the prenatal and immediate postnatal developmental stages, with this effect lasting over time," stated Dr. Ponzo during his presentation at the Chicago convention.
The Pervasive Presence of DEHP
Di-(2-ethylhexyl) phthalate, commonly known as DEHP, is a ubiquitous plasticizer employed to impart flexibility and durability to a vast array of plastic products. Its presence is so widespread that it is found in everyday items such as children’s toys, shower curtains, raincoats, and crucially, in numerous medical devices, including intravenous tubing and blood bags. This pervasive nature means that exposure, particularly for vulnerable populations like developing fetuses and infants, is a significant concern.
Previous scientific investigations have established that DEHP and its breakdown products can exert detrimental effects on multiple organ systems in both animal models and humans. The reproductive and nervous systems have been identified as particularly susceptible to these disruptions. Building upon this foundation, the University of Buenos Aires team aimed to specifically investigate DEHP’s influence on anxiety-related behaviors in adult male rats. Furthermore, their research sought to elucidate the potential roles of gamma-aminobutyric acid (GABA), a primary inhibitory neurotransmitter in the central nervous system, and testosterone, a key sex hormone, in mediating these behavioral alterations.
A Chronology of Exposure and Observation
The experimental design meticulously traced the impact of DEHP exposure from gestation through early adulthood. Pregnant female rats were administered daily oral doses of DEHP, commencing on the very first day of their pregnancy. This administration continued uninterrupted until the time of weaning, a critical period encompassing significant neurological and hormonal development in the offspring.
Following this developmental exposure phase, the male rat pups were allowed to mature. At 70 days of age, a stage considered adulthood for laboratory rats, the researchers initiated their behavioral assessments. The primary tool for evaluating anxiety was the elevated plus maze (EPM). This well-established behavioral paradigm leverages the innate aversion of rodents to open spaces and heights. The maze, configured in a plus-sign shape, features two enclosed arms and two open arms, elevated from the ground.
The researchers systematically recorded several key metrics during the EPM test for each rat. These included the frequency of entry into both open and enclosed arms, the duration of time spent in each type of arm, and the duration of immobility, a behavior known as "freezing time," which is often indicative of heightened fear or anxiety.
Unveiling the Neuroendocrine Connection: GABA and Testosterone
The study’s innovative approach extended to investigating potential counter-regulatory mechanisms. Ninety minutes prior to the EPM testing, specific groups of DEHP-exposed rats received pharmacological interventions. Some animals were treated with GABA agonists, substances designed to mimic and activate the inhibitory effects of GABA. Other rats were administered testosterone, given every 48 hours for a period of 14 days leading up to the behavioral assessments.
The results from the behavioral tests painted a clear picture. Male rats that had been exposed to DEHP during their early development, but received no subsequent intervention, exhibited pronounced signs of increased anxiety. These rats demonstrated a marked reluctance to explore the open arms of the elevated plus maze, opting instead to spend more time within the safety of the enclosed arms. Furthermore, they displayed significantly longer periods of freezing behavior, a behavioral correlate of heightened stress and apprehension.
In stark contrast, the DEHP-exposed rats that received either GABA agonists or testosterone treatments displayed a reversal of these anxiety-driven behaviors. Their exploration patterns shifted, with increased time spent in the open arms, indicating reduced fear of the exposed environment. This observed pattern strongly suggested that both GABAergic and androgenic pathways played a significant role in mediating the anxiety-inducing effects of early DEHP exposure and that their modulation could counteract these effects.
Expert Commentary and Scientific Significance
Dr. Ponzo elaborated on the implications of these findings, emphasizing the long-term nature of the observed effects. "This work demonstrates that contact with DEHP in the early stages of life could modify behavior with regard to anxiety, even in the absence of DEHP exposure in adulthood," he stated. "These neuroendocrine changes can be reversed by treating with GABA agonists or testosterone." This observation is particularly significant as it suggests that developmental exposures to EDCs can establish a lasting vulnerability to anxiety that persists long after the initial exposure has ceased.
Supporting Data and Scientific Context
While specific quantitative data from the ENDO 2026 presentation was not detailed in the initial release, the methodology employed is standard in behavioral neuroscience. Studies utilizing the elevated plus maze have consistently shown that increased time spent in open arms and more frequent entries into these arms correlate with lower anxiety levels in rodents. Conversely, increased freezing time and preference for enclosed arms are indicative of higher anxiety.
The role of GABA as the brain’s primary inhibitory neurotransmitter is well-established. Disruptions in GABAergic signaling have been implicated in various anxiety disorders. Similarly, testosterone, beyond its well-known roles in sexual development and reproduction, also influences neural circuits involved in mood and behavior. The study’s findings align with existing research suggesting that EDCs can interfere with the delicate balance of these neurochemical systems during critical developmental periods.
The endocrine system, which regulates hormones and their complex interactions, is particularly sensitive to disruption by EDCs. Phthalates, like DEHP, are known to interfere with hormone synthesis, metabolism, and signaling pathways. Their ability to mimic or block natural hormones can lead to a cascade of developmental abnormalities, affecting not only physical development but also brain structure and function, which in turn can manifest as behavioral changes.
Broader Implications and Potential for Human Health
Although the study was conducted in a rodent model, the biological mechanisms investigated—hormonal regulation, neurotransmitter function, and developmental plasticity—are conserved across species, including humans. The findings from this research warrant serious consideration regarding the potential impact of DEHP exposure on human mental health, particularly in children.
Given that DEHP is a ubiquitous component of many consumer products and medical materials, prenatal and early childhood exposure is a near certainty for a significant portion of the global population. The long-term consequences of such exposures, as suggested by this study, could contribute to the rising prevalence of anxiety disorders observed in many societies.
Future Directions and Public Health Considerations
The University of Buenos Aires study opens avenues for further research. Investigating the specific molecular pathways through which DEHP disrupts GABAergic and androgenic systems during development would provide a deeper understanding of the underlying mechanisms. Furthermore, epidemiological studies in human populations correlating early-life DEHP exposure with adult anxiety levels would be crucial for confirming these findings and assessing the magnitude of the risk.
The implications of this research also extend to regulatory bodies and public health initiatives. A stronger emphasis on phasing out or restricting the use of DEHP in products intended for children and medical applications where exposure is unavoidable may be warranted. The development of safer alternatives for plasticizers is an ongoing area of research and innovation within the chemical industry.
The scientific community’s ongoing efforts to understand the intricate interplay between environmental exposures and human health are vital. Research like that presented by Dr. Ponzo and his team at ENDO 2026 serves as a critical reminder that the chemicals we introduce into our environment can have profound and lasting effects on our well-being, underscoring the importance of proactive measures to protect public health.
